Juvenile rheumatoid arthritis: Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin- like growth factor binding proteins 1 and 3, and osteocalcin

Arthritis and Rheumatism

Volumn 40, Issue 2, 1997, Pages 332-340

  Davies, Ursula M ^a   Jones, Jennifer ^b   Reeve, Jonathan ^c   Camacho Hubner, Cecilia ^d   Charlett, André ^e   Ansell, Barbara M ^f   Preece, Michael A ^b   Woo, Patricia M M ^g  

^a EAST SURREY HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c Institute of Public Health   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f London Medical School ^*

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; OSTEOCALCIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GROWTH RETARDATION; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PREPUBERTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALYSIS OF VARIANCE; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOCALCIN;

EID: 0031042955     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400218     Document Type: Article

References (56)

1. Davies UM, Rooney M, Preece MA, Ansell BM, Woo P: Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 21:153-158, 1994
2. Ansell BM, Bywaters EGL: Growth in Still's disease. Ann Rheum Dis 15:295-319, 1956
3. Bernstein BH, Stobie D, Singsen BH, Koster-King K, Kornreich HK, Hanson V: Growth retardation in juvenile rheumatoid arthritis (JRA). Arthritis Rheum 20:212-216, 1977
4. Ansell BM, Bywaters EGL: Alternate-day corticosteroid therapy in juvenile chronic polyarthritis. J Rheumatol 1:176-186, 1974
5. Isaakson OGP, Jansson JO, Gause AM: Growth hormone stimulates lone bone growth directly. Science 216:1237-1239, 1982
6. D'Ercole AJ, Stiles AD, Underwood LE: Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine automne mechanisms of action. Proc Natl Acad Sci U S A 81:936-939, 1984
7. Baxter RC: Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr Scand 372:107-114, 1991
8. Baxter RC, Cowell CT: Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J Clin Endocrinol Metab 65:432-440, 1987
9. Price PA, Nishimoto SK: Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A 77:2234-2238, 1980
10. Silbergeld A, Litwin A, Bruchis S, Varsano I, Laron Z: Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clin Endocrinol 25:67-74, 1986
11. Hindmarsh PC, Matthews DR, deSilvio L, Kurtz AB, Brook CGD: Relationship between height velocity and fasting insulin concentrations. Arch Dis Child 63:665-666, 1988
12. Johansen JS, Giwercman A, Hartwell D, Nielsen CT, Price PA, Christiansen C, Skakkebaek NE: Serum bone Gla-protein as a marker of bone growth in children and adolescents: correlation with age, height, serum insulin-like growth factor I, and serum testosterone. J Clin Endocrinol Metab 67:273-278, 1988
13. Butenandt O, Kelch A, Rajmann E: Growth hormone studies in patients with rheumatoid arthritis with or without glucocorticoid therapy. Eur J Pediatr 118:53-62, 1974
14. Sturge RA, Beardwell C, Hartog M, Wright D, Ansell BM: Cortisol and growth hormone secretion in relation to linear growth: patients with Still's disease on different therapeutic regimens. BMJ 3:547-551, 1970
15. Allen JC, Jimenez M, Cowell CT: Insulin-like growth factor and growth hormone secretion in juvenile chronic arthritis. Ann Rheum Dis 50:602-606, 1991
16. Bennett AE, Silverman ED, Miller JJ III, Hintz RL: Insulin-like growth factors I and II in children with systemic onset juvenile arthritis. J Rheumatol 15:655-658, 1988
17. Aitman TJ, Palmer RG, Loftus J, Ansell BM, Royston JP, Teale JD, Clayton RN: Serum IGF-I levels and growth failure in juvenile chronic arthritis. Clin Exp Rheumatol 7:557-563, 1989
18. Unterman TG, Philips LS: Glucocorticoid effects on somatomedins and somatomedin inhibitors. J Clin Endocrinol Metab 61: 618-626, 1985
19. Reed A, Haugen M, Pachman LM, Langman CB: Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr 116:574-580, 1990
20. Reeve J, Loftus J, Hesp R, Ansell BM, Wright DJ, Woo PMM: Biochemical prediction of changes in spinal bone mass in juvenile chronic (or rheumatoid) arthritis treated with glucocorticoids. J Rheumatol 20:1189-1195, 1993
21. Kotowicz MA, Hall S, Hunder GG, Cedel SL, Mann KG, Riggs BL: Relationship of glucocorticoid dosage to serum bone Gla-protein concentration in patients with rheumatologic disorders. Arthritis Rheum 33:1487-1492, 1990
22. Butenandt O: Rheumatoid arthritis and growth retardation in children: treatment with human growth hormone. Eur J Pediatr 130:15-28, 1979
23. Svantesson H: Treatment of growth failure with human growth hormone in patients with juvenile chronic arthritis: a pilot study. Clin Exp Rheumatol 37:107-120, 1991
24. Darendilier F, Hindmarsh PC, Brook CGD: Dose-response curves for treatment with biosynthetic human growth hormone. J Endocrinol 125:311-316, 1990
25. Morrell DJ, Dadi J, More J, Taylor AM, Dabestani A, Buchanan CR, Holder AT, Preece MA: A monoclonal antibody to human insulin-like growth factor-1: characterization, use in radioimmunoassay and effect on the biological activities of the growth factor. J Mol Endocrinol 2:201-206, 1989
26. Povoa G, Roovete A, Hall K: Cross-reaction of serum monatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107:563-570, 1984
27. Loftus J, Allen R, Hesp R, Ansell BM, Woo P: Randomized, double-blind trial of deflazacort versus prednisolone in juvenile chronic arthritis. Pediatrics 88:428-436, 1991
28. International Committee for Standardization in Haematology: Guidelines on selection of laboratory tests for monitoring the acute phase response. J Clin Pathol 41:1203-1212, 1988
29. Blum WF: Insulin-like growth factors (IGFs) and IGF binding proteins in chronic renal failure: evidence for reduced secretion of IGFs. Acta Paediatr Scand 379 (Suppl):24-31, 1991
30. D'Ercole AJ, Underwood LE, van Wyk JJ: Serum somatomedn-C in hypopituitarism and other disorders of growth. J Paediatr 90:375-381, 1977
31. Rudman D, Kutner MH, Chawla RK: The short child with subnormal plasma somatomedin C. Pediatr Res 19:975-980, 1985
32. Clemmons DR, Klibanski A, Underwood LE, McArthur JW, Ridgway EC, Beitins IZ, van Wyk JJ: Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab 53:1247-1250, 1980
33. Ross R, Miell J, Freeman E, Jones J, Matthews D, Preece M, Buchanan C: Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-1. Clin Endocrinol 35:47-54, 1991
34. Bacon MC, White PH, Raiten DJ, Craft N, Margolis S, Levander OA, Taylor ML, Sami S, Lipnick RN, White PH: Nutritional status and growth in juvenile rheumatoid arthritis. Semin Arthritis Rheum 15:655-658, 1988
35. Dahn MS, Lange MP, Jacobs LA: Insulin-like growth factor-1 production is inhibited in human sepsis. Arch Surg 12:1409-1414, 1988
36. Cotterill AM, Holly JMP, Wass JAH: The regulation of insulin-like growth factor binding protein (IGFBP)-l during prolonged fasting, din Endocrinol 39:356-362, 1993
37. Cotterill AM, Daly F, Holly JMP, Cwyfan-Hughes S, Camacho-Hubner C, Abdulla F, Gale EA, Savage MO: The dawn phenomenon in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1. Clin Endocrinol 43:567-574, 1995
38. Taylor AM, Dunger DB, Preece MA, Holly JMP, Smith CP, Wass JA: The growth hormone independent insulin-like growth factor-1 binding protein BP-28 is associated with insulin-like growth factor inhibitory bioactivity in adolescent insulin-dependent diabetes. Clin Endocrinol 32:229-239, 1990
39. Unterman T, Oehler DT, Murphy LJ, Laoson RG: Multihormonal regulations of insulin-like growth factor binding protein-1 in rat H4E IIE hepatoma cells: the dominant role of insulin. Endocrinology 128:2693-2701, 1991
40. Snyder DK, Clemmons DR: Insulin-dependent regulation of insulin-like growth factor binding protein-1. J Clin Endocrinol Metab 71:1632-1636, 1990
41. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR: A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298, 1990
42. Jørgensen JO, Blum WF, Moller N, Ranke MB, Christiansen JS: Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH deficient patients. J Clin Endocrinol Metab 72:582-587, 1991
43. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Zachman NM, Christiansen C: Serum bone Gla-protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy. J Clin Endocrinol Metab 71:122-126, 1990
44. Ekenstam E, Stalenheim G, Hallgren R: The acute effect of high-dose corticosteroid treatment on serum osteocalcin. Metabolism 32:141-144, 1988
45. Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L: The effects of high-dose glucocorticoid administration on serum BGP, serum osteocalcin and vitamin D metabolites in normal subjects. Bone 4:105-113, 1988
46. Nilsson A, Carlsson B, Mathews L, Isaksson OGP: Growth hormone regulation of the growth hormone receptor mRNA in cultured rat epiphyseal chondrocytes. Mol Cell Endocrinol 70: 237-246, 1990
47. Nilsson A, Carlsson B, Isgaard J, Isaksson OGP, Rymo L: Regulation by GH of insulin-like growth factor-1 mRNA expression in rat epiphyseal growth plate as studied with in situ hybridization. J Endocrinol 125:67-74, 1990
48. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J: Actions of growth hormone - current views. Acta Paediatr Scand 343:12-18, 1988
49. Orlowski CC, Chernausek SD: Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 123:44-49, 1988
50. 3, parathyroid hormone, and glucocorticoids. Metab Bone Dis Rel Res 5:229-234, 1984
51. Kanzaki S, Baxter RC, Knutsen R, Bay link DJ, Mohan S: Evidence that human bone cells in culture secrete insulin-like growth factor IGF-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res 10:854-858, 1995
52. De Benedetti F, Massa M, Robbioni P, Ravelli A, Burgio GR, Martini A; Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum 34:1158-1163, 1991
53. Rooney M, David J, Symons J, Di Giovane F, Varsani H, Woo P: Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 34:454-460, 1995
54. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell RGG: An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306:378-380, 1983
55. Gowen M, Macdonald BR, Russell RGG: Actions of recombinant human γ-interferon and tumor necrosis factor α on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro. Arthritis Rheum 31:1500-1507, 1988
56. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto C, Roden GA, Costantini F: Interleukin-6 deficient mice are protected from bone loss caused by oestrogen depletion. EMBO J 13:1189-1196, 1994